VAXCYTE INC (PCVX) Stock Income Statement
NASDAQ:PCVX - Nasdaq - US92243G1085 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 635.89M | 569.55M | 393.04M | 209.26M | 103.67M | |||
| Research and Development | 530.19M | 476.64M | 332.34M | 135.68M | 60.94M | |||
| Selling, General, and Administrative Expenses | 105.20M | 92.90M | 60.70M | 73.59M | 42.74M | |||
| Operating Income | -635.89M | -569.55M | -393.04M | -209.26M | -103.67M | |||
| Interest Income/Expense | 129.78M | 109.99M | 61.01M | 6.88M | 2.01M | |||
| Other Income/Expense | -3.55M | -4.38M | 4.76M | 1.93M | 1.59M | |||
| Non Recurring Items | N/A | 0.00 | -75.00M | -23.04M | N/A | |||
| Income Before Taxes | -509.92M | -463.93M | -402.27M | -223.49M | -100.08M | |||
| Net Income | -509.92M | -463.93M | -402.27M | -223.49M | -100.08M | |||
| EBITDA | -616.17M | -553.70M | -382.87M | -206.68M | -101.87M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.98 | -3.80 | -4.14 | -3.44 | -1.93 | |||
| Non GAAP EPS | -3.98 | -3.79 | -4.13 | -3.43 | -1.93 | |||
| Statistics | ||||||||
All data in USD